Destiny Pharma plc (“Destiny Pharma” or “the Company”) Posting of Annual Report and Accounts, and Notice of AGM Brighton, United Kingdom – 27 April 2022 – Destiny Pharma plc (AIM: DEST) a […]
Tuesday April 12, 2022
Audited results for year ended 31 December 2021
Destiny Pharma plc (“Destiny Pharma” or “the Company”) Audited results for the year ended 31 December 2021 Good progress preparing NTCD-M3 Phase 3 programme targeting C. difficile infection recurrence Discussions […]